Innoviva Inc news

   Watch this stock
Showing stories 1 - 10 of about 81   

Articles published

INVA 10.48 -0.13 (-1.23%)
price chart
Tracking the Numbers for Innoviva, Inc. (NASDAQ:INVA)
Market watchers might be keeping an eye on Innoviva, Inc. (NASDAQ:INVA)'s Piotroski F-Score. The F-Score was created to help spot company stocks that have solid fundamentals, and to filter out weaker companies.
Innoviva Inc Risk Points versus Health Care
This is a scatter plot analysis of the critical risk points from the option market for Innoviva Inc (NASDAQ:INVA) compared to its own past and the Health Care ETF.
Enterprise Value Review for Innoviva, Inc. (NASDAQ:INVA)
Investors are paying increased attention to shares of Innoviva, Inc. (NASDAQ:INVA). The company currently has an EV or Enterprise Value of 1727674.
INNOVIVA,INC. (NASDAQ:INVA) Files An 8-K Other Events
Innoviva, Inc., formerly Theravance, Inc., focuses on bringing new medicines to patients in areas of unmet need. The Company is engaged in the development, commercialization and financial management of bio-pharmaceuticals.
GSK files regulatory submission in US for once-daily closed triple combination ...
LONDON, Nov. 21, 2016 /PRNewswire/ -- GlaxoSmithKline plc (LSE/NYSE: GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced the filing by GSK of a regulatory submission with the US Food and Drug Administration for the once-daily, closed triple ...
GlaxoSmithKline and Innoviva celebrate early FDA submission of COPD treatment  Proactive Investors UK
Theravance Biopharma (TBPH) Affirms Filing of FF/UMEC/VI Submission with FDA ...
Form 8-K Innoviva, Inc. For: Dec 01
On December 1, 2016, GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) announced the Japanese Ministry of Health, Labor and Welfare's approval of RELVAR� ELLIPTA� (fluticasone furoate / vilanterol 100/25 mcg), the first once-daily ICS/LABA ...
GSK Files Regulatory Submission In EU For Triple Combination Therapy On COPD  Nasdaq
Relvar Ellipta approved in Japan for COPD  London South East (registration) (blog)
Innoviva Inc Price Volatility Hits A Weakened Level
This is a proprietary price volatility rating created by Capital Market Laboratories (CMLviz) based on a large number of data interactions for Innoviva Inc (NASDAQ:INVA) . We also look at broad measures of the S&P 500 and Nasdaq 100 indices as well as ...
Does the hype around Innoviva Inc's (INVA) growth justify its November share ...
Innoviva Inc (NASDAQ:INVA) is considered a high growth stock but its last closing price of $9.64 made some investors wonder if it can be still rationalized by the high growth potential.
Innoviva, Inc. (NASDAQ:INVA) Approaching Earnings Date: What matter for investors?
Innoviva, Inc. (NASDAQ:INVA) gained 1.18% to reach at the trading price of $10.33 as it is set to release its next quarterly earnings report on February 09, 2017.
Innoviva Inc. (INVA) VP Theodore L. Witek, Jr. Sells 3700 Shares
Innoviva logo Innoviva Inc. (NASDAQ:INVA) VP Theodore L. Witek, Jr. sold 3,700 shares of the business's stock in a transaction that occurred on Tuesday, November 22nd.
Innoviva Inc. (INVA) CFO Eric Desparbes Sells 1800 Shares of Stock  BBNS